CERE - Cerevel Therapeutics Inc Qarzning balans kapitallashuviga nisbati
Tarixiy qarzning kitob kapitalizatsiyasiga nisbati epilepsiya va shizofreniyani davolash uchun innovatsion molekulalar ishlab chiquvchi Cerevel Therapeutics (CERE) kompaniyasining barqarorligini namoyish etadi. 0.88 darajasi rahbarlik sotib olishdan keyin ichki jarayonlarni integratsiya qilayotgan bir paytda ushbu metrikaning joriy qiymatini aks ettiradi. Ilmiy tadqiqotlarning barqarorligi farmatsevtika logistikasi ustidan qat'iy nazorat bilan to'ldirilgan bo'lib, bu bemorlar xavfsizligini va dori vositalarining yaxlitligini ta'minlaydi.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_CERE_-_Cerevel-Therapeutics_-_Debt-to-Net-Assets-Ratio "Cerevel Therapeutics, Inc. - CERE Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 10.08.2024) | 👁️GURU.Markets👁️")
Cerevel Therapeutics Inc (CERE) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Cerevel Therapeutics|CERE - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Cerevel|CERE - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar Cerevel Corp|CERE - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli majburiyatlari Cerevel Therapeutics
Kompaniyaning fundamental tahlili:Cerevel Therapeutics - CERE
Noaniqlik davrida kapitalni saqlab qolish uchun investorlarning qarz darajalarini kuzatib borishi muhimdir. Ushbu ko'rsatkich sof aktivlarga nisbatan qarz mablag'larining ulushini belgilab, kompaniyaning moliyaviy barqarorligini baholaydi. Majburiyatlarning kitob kapitalizatsiyasiga nisbatini tahlil qilish leverajning xavfli o'sishini o'z vaqtida aniqlashga yordam beradi. Ushbu koeffitsiyentni kamaytirish tebranishlar risklarini minimallashtiradi. Cerevel Therapeutics (CERE) uchun bunday barqarorlik neyrobiologiya sohasidagi tadqiqotlar va ishlanmalarni diversifikatsiya qilishda juda muhimdir.
Cerevel Therapeutics (CERE) raqobatchilari
Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|Xenon Corp (XENE) - Balans qiymatiga qarzlar|Balans kapitallashuviga qarzlar VKTX|Qarzning balans qiymatiga nisbati supernus.com|Catalyst Pharmaceuticals, Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar DNLI (Denali)|Qarzning balans kapitallashuviga nisbati Harmony Pharma|Qarzning sof aktivlarga nisbati Biohaven Corp BHVN|AMLX (Amylyx Pharmaceuticals) - Balans kapitallashuviga qarzlar|trevitherapeutics.com (TRVI) - Balans qiymatiga qarzlar|Praxis Precision Medicines, Inc. (PRAX) - Qarzning balans qiymatiga nisbati|Anavex (AVXL) - Qarzning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar CBLL (CeriBell Corp)|Balans qiymatiga qarzlar PRTA|Qarzning balans kapitallashuviga nisbati Alector, Inc. (ALEC)|Qarzning balans kapitallashuviga nisbati annexonbio.com ANNX|Qarzning balans qiymatiga nisbati Omeros|NGNE - Qarzning sof aktivlarga nisbati|Qarzning balans qiymatiga nisbati AC Immune Corp ACIU|VYGR - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Neumora Therapeutics NMRA|scilexholding.com (SCLX) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar TVGN (Tevogen Bio)|Balans qiymatiga qarzlar ACOG|Cognition Therapeutics (CGTX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati Inhibikase Pharma (IKT)|Balans kapitallashuviga qarzlar SAVA (Cassava Sciences, Inc.)|Assertio Holdings - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Coya|VTGN - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar OVID|Balans qiymatiga qarzlar Acumen Pharmaceuticals, Inc|CRVO (CervoMed Inc.) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Alterity Therapeutics Ltd (ATHE)|Qarzning balans qiymatiga nisbati Clene Inc.|Qarzning balans kapitaliga nisbati pepgen.com (PEPG)|Balans kapitallashuviga qarzlar JUNS|Sof aktivlarga qarzlar Relmada Corp RLMD|ANVS: Balans kapitallashuviga qarzlar|GRCE: Qarzning balans qiymatiga nisbati|Firefly Neuroscience - Qarzning balans kapitallashuviga nisbati|Klotho Neurosciences (KLTO) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar NRSN|Qarzning balans qiymatiga nisbati Reviva Pharmaceuticals, Inc.|MetaVia Inc - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar NRXS (neuraxis.com)|Qarzning balans kapitallashuviga nisbati Helius Medical Technologies|Qarzning sof aktivlarga nisbati Passage Bio Inc. PASG|NEUP (Neuphoria) - Balans kapitallashuviga qarzlar|NERV: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Athira Pharma, Inc.|addextherapeutics.com (ADXN) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar ALZN (Alzamend Neuro Inc.)|Balans qiymatiga qarzlar Cyclerion (CYCN)|Qarzning balans qiymatiga nisbati PTIX|Balans kapitallashuviga qarzlar KTTA (pasitheaclinics.com)|Qarzning balans kapitallashuviga nisbati Cortigent|avenuetx.com - Qarzning sof aktivlarga nisbati|BCLI (BrainStorm Cell Therapeutics) - Qarzning balans kapitallashuviga nisbati|CARA - Balans qiymatiga qarzlar|CHRO (Chromocell Therapeutics Corporation) - Balans kapitallashuviga qarzlar|Eliem Therapeutics Inc. (ELYM) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar ITCI (Intra-Cellular Therapies Inc.)|Balans qiymatiga qarzlar LBPH|Marinus Pharmaceuticals, Inc. (MRNS) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati NKGen Biotech Inc (NKGN)|NRBO: Balans kapitallashuviga qarzlar|SAGE - Balans qiymatiga qarzlar|SNPX - Qarzning balans qiymatiga nisbati|TRVN - Qarzning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar VIGL|WENA (Anew Medical Inc.) - Balans qiymatiga qarzlar